Guardant Health, Inc. (GH) vs IDEXX Laboratories, Inc. (IDXX)
Guardant Health, Inc. and IDEXX Laboratories, Inc. are both Diagnostics & Research companies. IDEXX Laboratories, Inc. is the larger, with a market value of $40.2B against $23.9B — 1.7× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; IDEXX Laboratories, Inc. trades at 36.2×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 12.8%. IDEXX Laboratories, Inc. has the higher net margin (25.0% vs −38.3%) and the higher return on invested capital (48.9% vs −129.7%). Across the 18 metrics below, IDEXX Laboratories, Inc. leads on 11 and Guardant Health, Inc. on 7.
Valuation
Profitability
| Metric | GH | IDXX | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.01% | 62.45% | 50.89% |
| Operating margin | (39.75%) | 32.03% | (8.57%) |
| Net margin | (38.33%) | 25.03% | (6.37%) |
| Free cash flow margin | (20.35%) | 27.17% | 0.00% |
| Return on equity | 171.64% | 74.21% | (2.92%) |
| Return on assets | (27.95%) | 33.65% | (6.71%) |
| Return on invested capital | (129.70%) | 48.87% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack